Exchange: OTC·Updated 09:59 AM EDT

KRBP Kiromic BioPharma Inc

$0.00
$0.00
(0.00%)
Today
Mkt Cap$2.00
Vol1.00

About KRBP

Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
30

Bearish Sentiment

How do you feel about KRBP?

Advertisement|Remove ads.